Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer
Abstract Background Fusobacterium nucleatum (F. nucleatum) is prevalent in colorectal cancer (CRC), and it can promote proliferation and induce chemoresistance via multiple pathways. The development of treatment strategies for F. nucleatum-infected CRC is of great importance. Methods Shotgun metagen...
Saved in:
| Main Authors: | Zhongkun Zhou, Yuqing Niu, Yunhao Ma, Dekui Zhang, Yiqing Wang, Rui Ji, Jianfang Zhao, Chi Ma, Hongmei Zhu, Yingqian Liu, Lixue Tu, Juan Lu, Baizhuo Zhang, Hua Zhang, Xin Ma, Peng Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Microbiome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40168-025-02133-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum‐infected Colorectal Cancer via Ecological Control
by: Zhongkun Zhou, et al.
Published: (2025-08-01) -
Targeted elimination of Fusobacterium nucleatum alleviates periodontitis
by: Nil Yakar, et al.
Published: (2024-12-01) -
The rise and evolving role of Fusobacterium nucleatum subspecies
by: Marietta Wolf, et al.
Published: (2025-01-01) -
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01) -
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
by: Chun Ye, et al.
Published: (2024-12-01)